Innospec Inc IOSP.OQ reported quarterly adjusted earnings of $1.39 per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of $1.28. The mean expectation of three analysts for the quarter was for earnings of $1.37 per share. Wall Street expected results to range from $1.37 to $1.38 per share.
Revenue fell 9.5% to $435.00 million from a year ago; analysts expected $480.40 million.
Innospec Inc's reported EPS for the quarter was $1.24.
The company reported quarterly income of $31.2 million.
Innospec Inc shares had fallen by 6.2% this quarter and lost 5.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 15.2% in the last three months.
In the last 30 days, there have been earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and "sell" or "strong sell."
The average consensus recommendation for the specialty chemicals peer group is also "buy"
Wall Street's median 12-month price target for Innospec Inc is $141.50
This summary was machine generated from LSEG data August 6 at 11:08 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING |
ESTIMATE |
ACTUAL |
BEAT, MET, MISSED |
Jun. 30 2024 |
1.37 |
1.39 |
Beat |
Mar. 31 2024 |
1.64 |
1.75 |
Beat |
Dec. 31 2023 |
1.62 |
1.84 |
Beat |
Sep. 30 2023 |
1.45 |
1.59 |
Beat |